NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology
April 10, 2024 09:00 ET
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., April 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving...
NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes
April 09, 2024 09:05 ET
|
NeuroOne Medical Technologies Corp
First to market FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control EDEN PRAIRIE,...
NeuroOne® to Participate in the 36th Annual Roth Conference
March 08, 2024 12:00 ET
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., March 08, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
NeuroOne® Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update
August 14, 2023 16:00 ET
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Aug. 14, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
NeuroOne® Submits 510(k) Application to FDA for OneRF™ Ablation System
June 12, 2023 08:35 ET
|
NeuroOne Medical Technologies Corp
Potential for transformative improvement in neurosurgery as first known sEEG-guided RF system that records and ablates nervous tissue with the added benefit of temperature control EDEN PRAIRIE,...
NeuroOne® Announces U.S. Commercial Launch of Evo® sEEG Electrodes
May 02, 2023 09:00 ET
|
NeuroOne Medical Technologies Corp
Evo sEEGs complementary to Zimmer Biomet’s robotic neurosurgery platform; strong market opportunity for paired technologies EDEN PRAIRIE, Minn., May 02, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical...